They also underlined that MMP-9 had a strong correlation with neutrophil counts and stressed that the new treatment methods targeting MMP-9 activity or neutrophil activation could be important options in the treatment of COVID-19-associated lung disease. The gene discussed is MMP9; the disease is COVID-19.